Published in Minerva Dietol Gastroenterol on October 21, 1985
HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol (1998) 3.05
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology (1982) 2.38
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet (1979) 2.29
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations. Aliment Pharmacol Ther (2012) 2.28
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05
Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol (1996) 2.01
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy (2010) 1.89
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology (1986) 1.75
Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther (2000) 1.73
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64
Detection of abnormal lesions recorded by capsule endoscopy. A prospective study comparing endoscopist's and nurse's accuracy. Dig Liver Dis (2006) 1.61
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1998) 1.60
Leptin expression in colorectal and breast cancer patients. Int J Mol Med (2000) 1.58
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut (2000) 1.48
IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? Eur J Gastroenterol Hepatol (1997) 1.47
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
NOD2/CARD15 in healthy relatives of IBD patients. Eur Rev Med Pharmacol Sci (2006) 1.41
Microscopic colitis progressed to collagenous colitis: a morphometric study. Ital J Gastroenterol (1996) 1.39
Helicobacter pylori infection and growth delay in older children. Arch Dis Child (1997) 1.39
Aminopyrine breath test. Dig Dis Sci (1994) 1.39
Striking aminotransferase rise after chlorhexidine self-poisoning. Lancet (1982) 1.38
Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology (1987) 1.35
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 1.28
Intrahepatic localization of the surface (HBsAg) and core (HBcAg) antigenic determinants associated with hepatitis B virus in biopsy samples from patients with liver disease. Ric Clin Lab (1976) 1.27
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol (1990) 1.24
Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery (1997) 1.24
Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. Gut (1976) 1.23
Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol (2004) 1.23
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology (1989) 1.23
Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol (2006) 1.18
Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol (1997) 1.17
Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol (2001) 1.17
An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. J Pathol (1979) 1.16
The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology (1997) 1.16
Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica (1982) 1.16
A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease. Gastroenterology (1981) 1.15
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. Aliment Pharmacol Ther (2001) 1.14
HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol (1999) 1.13
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol (2001) 1.13
IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine (2004) 1.13
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol (1998) 1.12
Treatment of antibiotic-resistant Helicobacter pylori. N Engl J Med (1998) 1.11
13C-octanoic acid breath test: a reliable tool for measuring gastric emptying. Ital J Gastroenterol Hepatol (1998) 1.10
Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology (1972) 1.09
Delta hepatitis--present status. J Hepatol (1985) 1.08
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int (2011) 1.08
Characteristics of hepatocellular carcinoma in Italy. J Hepatol (1998) 1.08
Treatment of medullary thyroid carcinoma: an update. Endocr Relat Cancer (2001) 1.05
Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet (2001) 1.05
Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut (2004) 1.03
Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine (2005) 1.03
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology (1995) 1.02
Liver transplantation in hepatitis delta virus disease. Lancet (1987) 1.02
Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test. Am J Dig Dis (1978) 1.01
The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest (1998) 1.01
Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology (1987) 0.99
Helicobacter pylori infection may undergo spontaneous eradication in children: a 2-year follow-up study. J Pediatr Gastroenterol Nutr (1998) 0.99
Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther (2006) 0.99
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology (1991) 0.98
An optimized experimental protocol based on neuro-evolutionary algorithms application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment. Artif Intell Med (2005) 0.97
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. Aliment Pharmacol Ther (2003) 0.97
Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol (1999) 0.97
Prenatal features of Noonan syndrome: prevalence and prognostic value. Prenat Diagn (2011) 0.97
Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol (2009) 0.95
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis. Dig Dis Sci (1999) 0.94
Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial. Colorectal Dis (2009) 0.94
Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. Gastrointest Endosc (1996) 0.94
Hepatitis delta virus infection of the liver: progress in virology, pathobiology, and diagnosis. Semin Liver Dis (1988) 0.94
Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients. Aliment Pharmacol Ther (2009) 0.94
G-cell counts in antral endoscopic biopsies by immunofluorescence. Scand J Gastroenterol (1977) 0.93
Ribavirin treatment for chronic hepatitis D: a pilot study. Liver (1994) 0.93
Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease. J Hepatol (1988) 0.93
13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol (2000) 0.93
Placebo controlled studies with ranitidine in duodenal ulcer. Scand J Gastroenterol Suppl (1981) 0.92
13C-breath tests in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci (2004) 0.92
Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology (1999) 0.92
Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol (1999) 0.92
A histological study of hepatitis delta virus liver disease. Hepatology (1987) 0.92
Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. J Endocrinol Invest (2004) 0.92
Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol (1995) 0.91
Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther (2004) 0.91
Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab (2001) 0.91
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy. Aliment Pharmacol Ther (2007) 0.90
[Intrahepatic cholestasis in hyperthyroidism]. Recenti Prog Med (1991) 0.90
Serum immunoreactive cationic trypsinogen response to secretin in normal subjects. Am J Gastroenterol (1983) 0.90
Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol (1993) 0.90
Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol (1997) 0.90
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther (2005) 0.90
Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther (2005) 0.90
Percutaneous implantation of arterial Port-a-cath via trans-subclavin access. Anticancer Res (2000) 0.90
Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol (1988) 0.89
The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2007) 0.89